Edgewise Therapeutics EWTX
$39.91 −$1.27 (-3.07%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $39.91 0.00%
Open$40.81
Prev close$41.17
Day range$39.71 – $41.41
Volume1.19M
Market cap$4.37B
P/E (TTM)4.8
Dividend yield–
Earnings
Average move on report day±2.9%last 7 reports
Closed higher2 of 729% of the time
Best reaction+2.0%
Worst reaction-4.3%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q1 | 7 May 2026 | Pre Market | ±10.8% | -3.81% | Within range |
| 2025/Q3 | 6 Nov 2025 | Pre Market | ±31.0% | -1.61% | Within range |
| 2025/Q2 | 7 Aug 2025 | Pre Market | ±12.0% | -4.18% | Within range |
| 2025/Q1 | 8 May 2025 | Pre Market | ±12.7% | +1.24% | Within range |
| 2024/Q3 | 7 Nov 2024 | Pre Market | ±13.0% | -3.25% | Within range |
| 2024/Q2 | 8 Aug 2024 | Pre Market | ±32.2% | +1.95% | Within range |
| 2024/Q1 | 9 May 2024 | Pre Market | – | -4.26% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$46.14M+1.5% YoY
Net profit$1.17B+2,967.6% YoY
Diluted EPS$9.65+2,574.4% YoY
Free cash flow-$78.31M-124.6% YoY
Operating cash flow-$78.29M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Return on equity92.1%
Return on assets85.4%
Return on invested capital90.1%
Current ratio12.30
Liabilities / assets8.3%
Cash & investments$1.74B
Total debt$2.36M
Net cash (debt)$1.74B
No comments yet — be the first to weigh in on EWTX.
Sign in to join the discussion.